Castelli Jeff 4
4 · AMICUS THERAPEUTICS, INC. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Castelli Jeff
Chief Development Officer
Transactions
- Award
Common Stock
2024-01-02+57,392→ 398,053 total - Tax Payment
Common Stock
2024-01-02$14.24/sh−8,038$114,461→ 390,015 total - Tax Payment
Common Stock
2024-01-03$13.53/sh−14,083$190,543→ 375,932 total - Award
Stock Options (right to buy)
2024-01-02+99,073→ 99,073 totalExercise: $14.24Exp: 2034-01-02→ Common Stock (99,073 underlying)
Footnotes (2)
- [F1]Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 2, 2025 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
- [F2]These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.